Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. MRK
4. BILL
5. MRNA
6. RARE
7. LOW
8. DE
9. COTY
10. URGN

Go back to Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
(NASDAQ: GNPX) Delayed: 3.99 --0 (-0%)
Previous Close $3.99    52 Week High $ 
Open $3.99    52 Week Low $ 
Day High $3.99    P/E N/A 
Day Low $3.99    EPS $ 
Volume 1,422